返回 Agenda
[V3-S3] TransCelerate: Innovation through Collaboration
Session Chair(s)
Norie Miki-Yasuda, PhD
Head of Clinical Operations Europe, Canada, Australia & New Zealand
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
“If you want to go fast, go alone; if you want to go far, go together.” Harnessing the power of collaboration can truly alter the healthcare landscape. This session will present TransCelerate’s perspectives around the next generation of collaborations. How will we need to work together differently as regulators, sponsors, patients, sites, and technologists are brought together? How can collaborations defy the bounds of innovation and accelerate disease prevention, diagnosis, treatment, and?—?ultimately?—?cures? This thought-provoking conversation will bring together a diverse panel of senior executives from TransCelerate Member Companies to discuss the many solutions that have been developed across 19 companies to evolve the clinical trials paradigm. Attendees will learn about how TransCelerate has been solving challenges with Regulators in the Pharmacovigilance space, redefining the Site Investigator experience through novel technologies, and utilizing model frameworks for eConsent and eLabels to progress the industry towards digitally-supported, patient-centric trials.
Speaker(s)
An Overview of TransCelerate BioPharma, Inc.
Gareth H Morgan, MBA, MS
Shionogi USA Inc., United States
Vice President, Management & Clinical Development
TransCelerate Activities in Japan
Toshiharu Sano, RPh
Japan Pharmaceutical Manufacturers Association, Japan
Vice-Chairperson, Drug Evaluation Committee
Key Initiative Update: Pharmacovigilance
Ken Kubota, PhD
Astellas Pharma Inc., United States
Vice President for Pharmacovigilance Operations
Key Initiative Update: SIP (Shared Investigator Platform)
Kouichi Mitsuhashi
MSD K.K., Japan
RBSL, Clinical Operations
eLabels in Clinical Supplies
Yosuke Chiyomori
Eli Lilly Japan K.K., Japan
Clinical Development Manager, Trial Mgmt,Clinical Development Ops & Innovations